Biotechnology on the Frontlines

In the beginning of 2021, the White House announced there would be increased U.S. investment in emerging technologies like biotechnology. How will these investments improve the development and adoption of biotechnology to support soldier operations? This session will highlight biotechnology’s role in addressing national security priorities.


Dr. Kayvon Modjarrad, M.D., Ph.D., Director of Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research
Dr. Dimitra Stratis-Cullum, Program Manager, Transformational Synthetic-Biology for Military Environments, U.S. Army Combat Capabilities Development Command, Army Research Laboratory
Tara Copp, Senior Pentagon Correspondent, Defense One